Start of Ebola Vaccination Campaign in Southern Congo

Vaccination has begun in southern Congo to combat a recent Ebola outbreak with over 68 suspected cases and 16 fatalities. The WHO is deploying vaccines and addressing access challenges to control the virus.
In a significant step to combat the ongoing Ebola outbreak, vaccination efforts have commenced in the southern region of Congo's Kasai province. The World Health Organization (WHO) announced that initial vaccinations target those exposed to the virus as well as frontline healthcare workers. The outbreak, characterized by its high contagion level, was officially declared earlier this month in the remote area of Bulape. So far, at least 16 fatalities have been reported, alongside 68 suspected cases, highlighting the severity of the situation.
The vaccination campaign is utilizing the Ervebo vaccine, with the first batch comprising 400 doses already dispatched to the region. Further vaccine supplies are anticipated as the International Coordinating Group on Vaccine Provision has approved an additional approximately 45,000 doses, supplementing the initial stockpile of 2,000 doses available in the country. However, challenges such as limited access to affected areas and scarce financial resources have hampered vaccination efforts.
This particular outbreak marks Congo’s 16th since the virus was first identified in 1976 and involves the Zaire species of Ebola, named after the country's former name. The situation is compounded by ongoing conflict and violence, especially in the eastern parts of the country, which have severely affected the health infrastructure. Despite these obstacles, health authorities continue to work diligently to contain the virus and prevent further spread.
Source: https://medicalxpress.com/news/2025-09-ebola-vaccination-southern-congo.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
How Chromosome Imbalances Affect Mitochondrial Function in Cancer Cells
A new study reveals how chromosome abnormalities in cancer cells impair mitochondrial function via protein aggregation, impacting cellular health and treatment strategies.
Genetic and Behavioral Connections Between Musical Rhythm Skills and Developmental Language Disorders
New research reveals the genetic and behavioral links between musical rhythm perception and developmental speech-language disorders, highlighting implications for diagnosis and therapy.
Innovative Smartphone-Operated Nerve Stimulator Helps Golfer Regain Mobility
A new smartphone-controlled spinal cord stimulator offers effective relief for neuropathy, enabling a golfer to return to playing after severe nerve pain. Discover how cutting-edge neuromodulation technology is transforming pain management and quality of life.
Breakthrough Phase III Clinical Trial Demonstrates Effectiveness of Gene-Engineered Skin Grafts in Healing Chronic Blistering Wounds in Dystrophic Epidermolysis Bullosa
A groundbreaking Phase III trial reveals that gene-engineered skin grafts significantly improve healing and quality of life for patients with severe dystrophic epidermolysis bullosa, a rare genetic skin disorder.